Citation
Shanshan Liang, Xinyu Wang, Jianxue Zhang, Chuanmin Tao, Wei Gan. The lipoprotein–immune checkpoint axis: Linking cardiovascular toxicity and antitumor immunity during immune checkpoint therapy. // Vascular Pharmacology. – 2026. – DOI: 10.1016/j.vph.2026.107719. – URL: https://doi.org/10.1016/j.vph.2026.107719
Shanshan Liang, Xinyu Wang, Jianxue Zhang, Chuanmin Tao, & Wei Gan (2026). The lipoprotein–immune checkpoint axis: Linking cardiovascular toxicity and antitumor immunity during immune checkpoint therapy. Vascular Pharmacology. https://doi.org/10.1016/j.vph.2026.107719
Shanshan Liang, et al. “The lipoprotein–immune checkpoint axis: Linking cardiovascular toxicity and antitumor immunity during immune checkpoint therapy.” Vascular Pharmacology, 2026. doi:10.1016/j.vph.2026.107719.
@article{Liang2026,
title = {The lipoprotein–immune checkpoint axis: Linking cardiovascular toxicity and antitumor immunity during immune checkpoint therapy},
author = {Liang, Shanshan and Wang, Xinyu and Zhang, Jianxue and Tao, Chuanmin and Gan, Wei},
journal = {Vascular Pharmacology},
year = {2026},
doi = {10.1016/j.vph.2026.107719},
url = {https://doi.org/10.1016/j.vph.2026.107719}
}